Higher Levels of Leflunomide Are Associated with Hemolysis and Are not Superior to Lower Levels for BK Virus Clearance in Renal Transplant Patients | Zendy

Nicolae Leca | Zendy; Kimberly A. Muczynski | Zendy; Jonathan Ashley Jefferson | Zendy; Ian H. de Boer | Zendy; Jolanta Kowalewska | Zendy; Elizabeth Kendrick | Zendy; Raimund Pichler | Zendy; Connie L. Davis | Zendy

Open Access

Higher Levels of Leflunomide Are Associated with Hemolysis and Are not Superior to Lower Levels for BK Virus Clearance in Renal Transplant Patients

Author(s) -

Nicolae Leca,

Kimberly A. Muczynski,

Jonathan Ashley Jefferson,

Ian H. de Boer,

Jolanta Kowalewska,

Elizabeth Kendrick,

Raimund Pichler,

Connie L. Davis

Publication year - 2008

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.03930907

Subject(s) - leflunomide , medicine , bk virus , renal function , nephropathy , microangiopathy , urology , transplantation , gastroenterology , creatinine , hemolysis , kidney transplantation , endocrinology , diabetes mellitus , rheumatoid arthritis

Leflunomide use in renal transplantation has been increasing. Outcome correlation and safety data are still to be refined. The goals of this study were to report one center's experience with leflunomide, specifically the correlation of leflunomide levels with the outcomes of BK nephropathy and the observed toxic effects during the treatment with leflunomide.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research